Saturday 26/11/2016 23/11
Khawarizmi International College (KIC) organizes the first scientific forum in the field of Health and Medical Sciences
Naeem Radi: the forum coincides with the celebrations of the state National Innovation Week
Khawarizmi International College organized the first scientific forum of Health and Medical Science at its first session on Breast Cancer Research. The forum hosted international and national scientists and practitioners who presented their latest research findings. Presenters reviewed the latest diagnostic and therapeutic practices regarding this disease and ways and means of raising awareness to prevent it and reduce the complications of radiotherapy. The first speaker was Professor Nigel Crompton from Cornerstone University, Michigan, USA who presented a scientific study regarding a newly developed predictive test of the severity of late effects to healthy tissues following radiation therapy. The study showed that this test is rapid, highly reproducible, and time and cost effective. The application of this test for hundreds of thousands of patients will mean the difference between confidence in a potentially lifesaving therapy or devastating loss in quality of life. Professor Crompton revealed in his talk some of the results of a retrospective and a prospective Swiss study which accurately predicted radiosensitive patients suffering from the late effects of radiation therapy. Patients whose blood cells showed low levels of cell death after exposure to radiation were susceptible to the late effects of radiotherapy whereas high levels correlated with a healthy clinical response. A French Clinical trial of more than 500 breast cancer patients has recently been published to support the value of the test to clinicians and patients alike.
Dr Syed Mansoor Hasnain, Consultant Radiation Oncologist, Tawam Hospital was the next to present his study regarding treatment modalities for breast cancer patients in the UAE. The talk demonstrated among other things the role the Chemotherapy, Radiotherapy, and other supportive departments such as National Cancer Referral Centre and Tawam Hospital Breast Cancer Centre in UAE, are playing in tackling the growing needs of effective treatment of cancer patients, especially breast cancer patients. According to the SEHA Central Cancer Registry, breast cancer patients constitute more than 33% of total cancer patients among Nationals and more that 45% among residents.
Similar data of UAE cancer patients’ statistics compared to world-wide incidence was shown by the third speaker, Dr Muneezeh Liaqat from Pathology and Laboratory Medicine Institute, Cleveland Clinic Abu Dhabi. Dr Liaqat also showed the top ten types of cancer in the UAE and related statistics in terms of gender. Her presentation also focused on the importance of screening programs and how they have been proven to result in a substantial reduction in mortality from cancer and in particular breast cancer through routine mammography screening.
The fourth speaker, Dr Gehad ElGhazali from Sheikh Khalifa Medical City described the relationship between Breast cancer and the Immune system with emphasis on possible reasons of low immunogenicity in breast cancer cells.
The colloquium is the first step of a broader project to investigate and promote the implementation of the advanced technology of the Lymphocyte Apoptosis Assay (LAA) in the treatment of cancer patients in the UAE to predict a negative response to radiation therapy. The assay helps both hypersensitive individuals by permitting appropriate therapies to be selected; and resistant individuals by increasing cure rates. The LAA presents a road map for the future to determine the mechanism of treatment for each cancer patient taking the necessary measures to limit any negative side-effects stemming from radiation therapy.